Effects of Resistance Sprint Training With and Without Power Training on Sprint and Agility Performance

April 30, 2024 updated by: Sehat Medical Complex

Effects of Resistance Sprint Training With and Without Power Training on Sprint and Agility Performance in Football Players

This study will be randomized clinical trial will be used to get expected outcomes. Hence under ethical consideration athletes of Pakistan football federation will go under the selection criteria and chosen voluntarily to participate in the study. Data will be collected with non-probability convenient sampling technique and 40 football players will be participated in this study. Participates will be divided into two groups with randomization process. 20 athletes will be in each group. Group A will be treated with squats jumps, change of direction speed, countermovement jump, bench press, Romanian deadlift and barbell squats, resistance band sprints, stair sprints and weighted sled pulls and Group B will be treated with squats jumps, change of direction speed, countermovement jump, resistance band sprints, stairs sprints and weighted sled pulls. These exercises will be given in 3 sets with 10 repetitions in each set. Pre and post interventions measures will be taken on 1st day and at 6th week there will be 3 sessions in a week. SPSS version 25 will be used to analyze the data.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Football is a sport which is of high-intensity intermittent game that requires players to be physically capable of coping with high-intensity movements, having repeated changes of direction, sprints, and accelerations/decelerations, with complex and physically demanding technical different actions Developing and loading strength techniques in football come from knowledge of game performance and its specific components and limitation components. Most of the important factors in football are explosiveness activities such as changing direction, jumping, sprinting, and kicking. Working on these explosive performances have been found after strength training that improved the available force of muscular contraction in appropriate muscle groups. Vertical jump and sprint performances are interlinked with maximal muscular strength in football players and the heavy resistance training can also increase running economy and which ultimately increases the aerobic performance of the athlete

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
38

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan, 44000
        • Riphah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male football players
  • Age 18- 40 years
  • BMI 18.5-25
  • Being volunteered to participate in study
  • Being engaged in practice from past 6th month

Exclusion Criteria:

  • Athlete with current substance abuse
  • Individual diagnose with severe anxiety disorder and psychosis
  • History of previous fracture from last 6 months
  • Musculoskeletal disorders (sprains, strains, tendinopathies, stress fracture)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Power training Group
with baseline intervention and power training interventions
Other: with baseline intervention and power training interventions

Group A (with power training ) was treated with

  • squats jump,
  • change of direction speed,
  • countermovement jump,
  • bench press,
  • Romanian deadlift
  • barbell squats,
  • resistance band sprints,
  • stair sprints
  • weighted sled pulls
Other: Baseline Group
baseline interventions and without power training interventions
Other: baseline interventions and without power training interventions

Group B (without power training) was treated with

  • squats jump
  • change of direction speed
  • countermovement jump
  • barbell squats
  • resistance band sprints
  • stair sprints
  • Weighted sled pulls.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Resisted sprinting speeds at 10-30 m
Time Frame: Change from Baseline at 6 weeks
The athlete sprints a distance of 10-30m while pushing or pulling against resistance. This resistance can be provided by various means, such as sled, resistance band, or a partner holding onto a harness worn by athlete. A study suggested that the magnitude of the correlation coefficient between speed-test results and match parameters was considered as small (0.1 ≤ r < 0.3), moderate (0.3 ≤ r < 0.5), large (0.5 ≤ r < 0.7), very large (0.7 ≤ r < 0.9), and nearly perfect (r ≥ 0.9)
Change from Baseline at 6 weeks
Change of direction speed (COD) testing
Time Frame: Change from Baseline at 6 weeks
This test consists of four 5-m sections marked with cones set at 100° angles. Three maximal attempts were performed with a 5-min rest interval between attempts. Starting from a standing position with the front foot placed 0.3 m behind the first pair of photocells i.e., starting line athletes ran and changed direction as quickly as possible until crossing the second pair of photocells placed 20 m from the starting line .A study suggests a near perfect correlation between the COD (r=0.92)
Change from Baseline at 6 weeks
Squat jumps (SJ)
Time Frame: Change from Baseline at 6 weeks
In the SJ, a static position with a 90° knee flexion angle was maintained for 2 seconds before every jump attempt. No preparatory movement was allowed and an experienced researcher visually inspected for proper technique. A study suggested that jumping tests had high correlation coefficients with the principal component (r = 0.76-0.87.
Change from Baseline at 6 weeks
Countermovement Jump (CMJ)
Time Frame: Change from Baseline at 6 weeks
In the CMJ, athletes were instructed to perform a downward movement followed by a complete extension of the lower limbs and were allowed to freely determine the amplitude of the countermovement to avoid changes in their jumping coordination pattern. Participants were instructed to assume the same body position at takeoff and landing on both squat and counter movement jumps) the CMJ tests had a high correlation coefficient with the principal component (r=0.76-0.87)
Change from Baseline at 6 weeks
Horizontal Jump (HJ)
Time Frame: Change from Baseline at 6 weeks
The athlete stands behind a line marked on the ground with feet slightly apart. A two-foot take-off and landing is used, with swinging of the arms and bending of the knees to provide forward drive. The subject attempts to jump as far as possible, landing on both feet without falling backwards. Three attempts are allowed a study suggested a Horizontal jump assessment(r=-0.7-0.86)
Change from Baseline at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Sehat Medical Complex

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Imran Ghafoor, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 23, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 30, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 15, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 19, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 19, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 27, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 2, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 30, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • REC/RCRS/1021 Tehreem

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings